Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 26, 2025 07:15 ET | Source: Research and Markets

Monoclonal Antibody Collaboration and Licensing Agreements Trends Analysis Report 2025 with Directory of 670 Deals Signed Since 2019 by Company A-Z, Therapy Focus and Technology Type

Dublin, Nov. 26, 2025 (GLOBE NEWSWIRE) -- The "Monoclonal Antibody Collaboration and Licensing Deals 2019-2025" has been added to ResearchAndMarkets.com's offering.This report contains a...
November 20, 2025 08:00 ET | Source: Medela

Medela’s 2025 Global Breastfeeding & Lactation Symposium Series Unites Experts Across Three Continents to Advance Maternal and Infant Health

Baar, Switzerland, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Medela, a global leader in breast milk and healthcare technology, continues its legacy of advancing lactation science and clinical education...
November 18, 2025 04:16 ET | Source: Research and Markets

Pharmaceuticals and Biotechnology Option and Evaluation Deals Trends Analysis Report 2025 with Directory of Deals by Company A-Z, Therapy Focus and Technology Type

Dublin, Nov. 18, 2025 (GLOBE NEWSWIRE) -- The "Option and Evaluation Deals in Pharmaceuticals and Biotechnology 2019-2025" report has been added to ResearchAndMarkets.com's offering.Fully revised...
November 18, 2025 04:09 ET | Source: Research and Markets

Pharmaceuticals Collaboration Agreements Analysis Report and Directory of Deals 2025: Track Trends, Benchmark Valuations, and Access Detailed Contract Terms from 2020 Onward

Dublin, Nov. 18, 2025 (GLOBE NEWSWIRE) -- The "Collaboration Deals in Pharmaceuticals 2020-2025" has been added to ResearchAndMarkets.com's offering.This report contains a comprehensive listing of...
November 18, 2025 04:07 ET | Source: Research and Markets

Pharmaceuticals Licensing Deals Trends Analysis Report 2025: Trend Tracking, Valuation Benchmarks, Deal Directories, and Contract Insights for Faster, Informed Due Diligence

Dublin, Nov. 18, 2025 (GLOBE NEWSWIRE) -- The "Licensing Deals in Pharmaceuticals 2020-2025" has been added to ResearchAndMarkets.com's offering.The report provides access to licensing deal payment...
November 10, 2025 13:46 ET | Source: NeXtGen Biologics

NeXtGen Biologics and Lovell® Government Services Partner to Bring Innovative Advanced Wound Care Technology to Federal Healthcare Systems

NeXtGen Biologics and Lovell® Government Services Partner to Bring Innovative Advanced Wound Care Technology to Federal Healthcare Systems
November 05, 2025 16:05 ET | Source: BioStem Technologies, Inc.

BioStem Technologies Provides Comments on CMS CY 2026 Final Medicare Reimbursement Rule Changes for Skin Substitutes

BioStem Technologies Provides Comments on CMS CY 2026 Final Medicare Reimbursement Rule Changes for Skin Substitutes
November 05, 2025 07:00 ET | Source: BioStem Technologies, Inc.

BioStem Technologies Secures Land Purchase at the Research Park at Florida Atlantic University in Boca Raton for Future Headquarters

BioStem Technologies Secures Land Purchase at the Research Park at Florida Atlantic University in Boca Raton for Future Headquarters
November 03, 2025 08:00 ET | Source: Halberd Corp.

Halberd Corporation Continues Seeking Government Contracts with Scientists at Mississippi State University

Halberd Corporation Continues Seeking Government Contracts with Scientists at Mississippi State University
October 31, 2025 07:00 ET | Source: BioStem Technologies, Inc.

BioStem Technologies Reports Positive Top-Line Clinical Results Demonstrating Superior Outcomes with BioRetain® Allograft in Diabetic Foot Ulcers

BioStem Technologies Reports Positive Top-Line Clinical Results Demonstrating Superior Outcomes with BioRetain® Allograft in Diabetic Foot Ulcers